Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

- FDA Commissioner Scott Gottlieb announces resignation - London man becomes second in world to be cured of HIV - Indian government set to colour...
Roche has announced the approval of the European Commission for its PD-L1 inhibitor Tecentriq (atezolizumab) when used in combination with Avastin...
A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics kit after the...
The humanitarian organisation Médecins Sans Frontières (MSF) has called on The Coalition for Epidemic Preparedness Innovations (CEPI) to revise...
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with the...
The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s CIII nasal spray Spravato (...
Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra has been recommended by the EMA’s CHMP for...
AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for...
As part of an effort to promote low cost medicines the Indian government has announced plans to colour code generic drugs.
Canadian physicians have called on the federal government to review its funding for a programme which sends volunteer homeopaths to Honduras.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches